Back to Journals » Drug Design, Development and Therapy » Volume 11

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
11,176 Dovepress* 7,740 1,809+ 1,125 9,549
PubMed Central* 0 1,627 456 1,627
Totals 7,740 3,436 1,581 11,176
*Since 5 July 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 1 4 12

View citations on PubMed Central and Google Scholar